Showing results (11-20 of 17) with videos related to
Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 17 results.
The Journal of Steroid Biochemistry and Molecular Biology|December 3, 2014
Immunomodulatory effects of 25-hydroxyvitamin D3 on monocytic cell differentiation and influence of vitamin D3 polymorphisms in type 1 diabetesSabrina Mauf, Marissa Penna-Martinez, Thorsten Jentzsch, et al.Blood|April 5, 2007
Kinase domain mutations of BCR-ABL frequently precede imatinib-based therapy and give rise to relapse in patients with de novo Philadelphia-positive acute lymphoblastic leukemia (Ph+ ALL)Heike Pfeifer, Barbara Wassmann, Anna Pavlova, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 29, 2003
Risk and prognosis of central nervous system leukemia in patients with Philadelphia chromosome-positive acute leukemias treated with imatinib mesylateHeike Pfeifer, Barbara Wassmann, Wolf-Karsten Hofmann, et al.Blood|April 9, 2005
Early molecular response to posttransplantation imatinib determines outcome in MRD+ Philadelphia-positive acute lymphoblastic leukemia (Ph+ ALL)Barbara Wassmann, Heike Pfeifer, Michael Stadler, et al.Blood|October 25, 2003
Early prediction of response in patients with relapsed or refractory Philadelphia chromosome-positive acute lymphoblastic leukemia (Ph+ALL) treated with imatinibBarbara Wassmann, Heike Pfeifer, Urban J Scheuring, et al.Blood|April 28, 2006
Alternating versus concurrent schedules of imatinib and chemotherapy as front-line therapy for Philadelphia-positive acute lymphoblastic leukemia (Ph+ ALL)Barbara Wassmann, Heike Pfeifer, Nicola Goekbuget, et al.Virchows Archiv : an International Journal of Pathology|June 18, 2024
Expression of the tumor antigens NY-ESO-1, tyrosinase, MAGE-A3, and TPTE in pediatric and adult melanoma: a retrospective case control studyStephan Forchhammer, Oltin Tiberiu Pop, Matthias Hahn, et al.Pageof 2